Static Chart Daxor Corporation

Equities

End-of-day quote Nasdaq Other stock markets 23:00:00 04/06/2024 BST			5-day change	1st Jan Change
8.635 ^USD	-1.43%		-1.43%	-10.05%

06-05	Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer	CI
04-16	Daxor Corporation Announces Two New Studies Validating the Clinical Benefits of Daxor?s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion	CI

Duration

Period